NCT06047912 (PURL) is a clinical trial in Hypertension, sponsored by Dr Ian B Wilkinson.

Who is sponsoring NCT06047912?

NCT06047912 is sponsored by Dr Ian B Wilkinson.

What condition does NCT06047912 study?

NCT06047912 studies Hypertension, Primary Aldosteronism, Urine Aldosterone.

Is NCT06047912 still recruiting?

NCT06047912 is currently status unknown. Last updated 21 September 2023.

Last reviewed 2023-09-21 · How we verify

NCT06047912: PURL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Screening for Primary Aldosteronism in Hypertension With 24-hour URinary aLdosterone

Status unknown Last updated 21 September 2023

What this trial tests

trial in Hypertension in 120 participants. Status unknown.

Timeline

15 September 2023

Primary endpoint
30 September 2024

30 December 2024

Quick facts

Lead sponsor	Dr Ian B Wilkinson
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	120
Start date	15 September 2023
Primary completion	30 September 2024
Estimated completion	30 December 2024
Sites	1 location across United Kingdom

Conditions studied

Hypertension — all drugs for Hypertension →
Primary Aldosteronism — all drugs for Primary Aldosteronism →
Urine Aldosterone — all drugs for Urine Aldosterone →

Sponsor

Dr Ian B Wilkinson

Who can join

Adults 18 to 75, any sex, with Hypertension or Primary Aldosteronism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an observational study compares the positivity rates of two tests for screening for primary aldosteronism: plasma aldosterone renin ratio and 24-hour urine aldosterone in patients with young-onset hypertension with or without other clinical features of primary aldosteronism.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06047912 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr Ian B Wilkinson
Last refreshed: 21 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06047912.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing